This patent document relates to antibodies, antigen-binding antibody fragments (Fabs), and other protein scaffolds, directed against human antithrombin [beta] complexed with heparin and/or heparin-like structure (AT[beta]H). These AT[beta]H binding proteins can block the anti-coagulant activity of AT[beta] to induce coagulation. Therapeutic uses of these antibodies and binders are described herein as are methods of panning and screening specific antibodies.